138 related articles for article (PubMed ID: 38305486)
1. Changes in the numbers of hospital-based abortions and outpatient early medical abortions in Victoria, 2012-22: a retrospective cohort study.
Marzan MB; Johnson E; Moore P; Jiang H; Hui L
Med J Aust; 2024 Feb; 220(3):145-153. PubMed ID: 38305486
[TBL] [Abstract][Full Text] [Related]
2. Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022 : An Interrupted Time-Series Analysis.
Hwang CS; Kesselheim AS; Sarpatwari A; Huybrechts KF; Brill G; Rome BN
Ann Intern Med; 2023 Nov; 176(11):1508-1515. PubMed ID: 37871317
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
[TBL] [Abstract][Full Text] [Related]
4. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
[TBL] [Abstract][Full Text] [Related]
5. The impact of the COVID-19 pandemic on abortion care utilization and disparities by age.
Fulcher IR; Onwuzurike C; Goldberg AB; Cottrill AA; Fortin J; Janiak E
Am J Obstet Gynecol; 2022 Jun; 226(6):819.e1-819.e15. PubMed ID: 35114184
[TBL] [Abstract][Full Text] [Related]
6. An exploratory study of COVID-19-related changes in abortion service availability and use in Washington, DC, Maryland, and Virginia.
Bell SO; Berger BO; Sufrin C; Dozier JL; Burke AE
Perspect Sex Reprod Health; 2023 Mar; 55(1):12-22. PubMed ID: 36751866
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Cost-Effectiveness Analysis of Mifepristone-Misoprostol Medical Abortions in the First Year at the Regina General Hospital.
Hunter C; Jensen J; Imeah B; McCarron M; Clark M
J Obstet Gynaecol Can; 2021 Feb; 43(2):211-218. PubMed ID: 33153943
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
[TBL] [Abstract][Full Text] [Related]
9. [Induced abortion and COVID-19 : What changed with the pandemic in 2020].
Diakiese BM; Féron V
Rev Epidemiol Sante Publique; 2022 Nov; 70(6):277-285. PubMed ID: 36123204
[TBL] [Abstract][Full Text] [Related]
10. Abortion surveillance--United States, 2009.
Pazol K; Creanga AA; Zane SB; Burley KD; Jamieson DJ;
MMWR Surveill Summ; 2012 Nov; 61(8):1-44. PubMed ID: 23169413
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 on abortion method under ten weeks gestational age in Southern California.
Sullender RT; Jacobs M; Bukowski K; Marengo A; Mody SK; Averbach SH
Contraception; 2022 Jun; 110():56-60. PubMed ID: 35263650
[TBL] [Abstract][Full Text] [Related]
12. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
Warden S; Genkin I; Hum S; Dunn S
J Obstet Gynaecol Can; 2019 May; 41(5):647-652. PubMed ID: 31007171
[TBL] [Abstract][Full Text] [Related]
13. Geographic disparities in disruptions to abortion care in Louisiana at the onset of the COVID-19 pandemic.
Berglas NF; White K; Schroeder R; Roberts SCM
Contraception; 2022 Nov; 115():17-21. PubMed ID: 35921871
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study.
Upadhyay UD; Raymond EG; Koenig LR; Coplon L; Gold M; Kaneshiro B; Boraas CM; Winikoff B
JAMA Intern Med; 2022 May; 182(5):482-491. PubMed ID: 35311911
[TBL] [Abstract][Full Text] [Related]
15. Abortion surveillance - United States, 2010.
Pazol K; Creanga AA; Burley KD; Hayes B; Jamieson DJ;
MMWR Surveill Summ; 2013 Nov; 62(8):1-44. PubMed ID: 24280963
[TBL] [Abstract][Full Text] [Related]
16. Impact of approval of home use of misoprostol in England on access to medical abortion: An interrupted time series analysis.
Lewandowska M; Carter DJ; Gasparrini A; Lohr PA; Wellings K
Int J Gynaecol Obstet; 2024 Jan; 164(1):286-297. PubMed ID: 37621171
[TBL] [Abstract][Full Text] [Related]
17. Abortion surveillance--United States, 2008.
Pazol K; Zane SB; Parker WY; Hall LR; Berg C; Cook DA;
MMWR Surveill Summ; 2011 Nov; 60(15):1-41. PubMed ID: 22108620
[TBL] [Abstract][Full Text] [Related]
18. Risk of surgical evacuation and risk of major surgery following second-trimester medical abortion in Denmark: A nationwide cohort study.
Meaidi A; Jasmin Friedrich S; Lidegaard Ø
Contraception; 2020 Sep; 102(3):201-206. PubMed ID: 32511945
[TBL] [Abstract][Full Text] [Related]
19. Abortion Surveillance - United States, 2015.
Jatlaoui TC; Boutot ME; Mandel MG; Whiteman MK; Ti A; Petersen E; Pazol K
MMWR Surveill Summ; 2018 Nov; 67(13):1-45. PubMed ID: 30462632
[TBL] [Abstract][Full Text] [Related]
20. Abortion Surveillance - United States, 2014.
Jatlaoui TC; Shah J; Mandel MG; Krashin JW; Suchdev DB; Jamieson DJ; Pazol K
MMWR Surveill Summ; 2018 Nov; 66(25):1-44. PubMed ID: 30462631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
